zanadio
Commercial- Indications
- Obesity
Company intelligence / Profile preview
aidhere developed zanadio, one of the first digital therapeutics for obesity to be included in Germany’s DiGA formulary, with over 50,000 prescriptions fulfilled. Its PDTs are recognized as market-leading within regulated European frameworks. The company also developed PINK! Coach for breast cancer support. Both products have demonstrated significant uptake among prescribers and patients within statutory health insurance systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on aidhere.